Vigene Biosciences, Inc. — Form D
Vigene Biosciences, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-30. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-03-30
- Form: D
- Accession: 0001767643-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Minimum investment: $570K
- Investors: 2
- Date of first sale: 2020-03-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-363874
Issuer
- Name: Vigene Biosciences, Inc.
- CIK: 0001767643
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 5 Research Court, ROCKVILLE, MD, 20850
- Phone: 301-251-6638
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Zairen Sun | Executive Officer | Rockville, MD |
Other filings by this issuer (1)
More